Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
在市場動盪和不確定時期，許多投資者轉向股息收益率股票。這些公司通常具有較高的自由現金流，並以高額的股息支付來獎勵股東。
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.
Benzinga的讀者可以通過訪問我們的分析師股票評級頁面來查看分析師對他們最喜歡的股票的最新看法。交易者可以對Benzinga龐大的分析師評級數據庫進行排序，包括按分析師的準確性進行排序。
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
以下是最準確的分析師對醫療保健行業三隻高收益股票的評級。
Pfizer Inc. (NYSE:PFE)
輝瑞公司（紐約證券交易所代碼：PFE）
- Dividend Yield: 5.96%
- Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and increased the price target from $28 to $29 on May 2. This analyst has an accuracy rate of 70%.
- BMO Capital analyst Evan David Seigerman reiterated an Outperform rating and raised the price target from $33 to $36 on May 2. This analyst has an accuracy rate of 68%.
- Recent News: Pfizer has reportedly settled 10,000 lawsuits alleging it concealed the cancer risks associated with its Zantac heartburn medication, marking the largest resolution in the litigation.
- 股息收益率：5.96%
- 摩根士丹利分析師特倫斯·弗林維持同等權重評級，並於5月2日將目標股價從28美元上調至29美元。該分析師的準確率爲70％。
- BMO Capital分析師埃文·戴維·塞格曼重申了跑贏大盤的評級，並於5月2日將目標股價從33美元上調至36美元。該分析師的準確率爲68％。
- 最近的新聞：據報道，輝瑞已經和解了10,000起訴訟，指控其隱瞞了與Zantac胃灼熱藥物相關的癌症風險，這是該訴訟中最大的解決方案。
Organon & Co. (NYSE:OGN)
Organon & Co.（紐約證券交易所代碼：OGN）
- Dividend Yield: 5.46%
- Piper Sandler analyst DavidAmsellemmaintained an Overweight rating and raised the price target from $22 to $24 on April 29. This analyst has an accuracy rate of 66%.
- Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and cut the price target from $27 to $22 on Oct. 11, 2023. This analyst has an accuracy rate of 70%.
- Recent News: Organon announced pricing of $1.0 billion senior notes offering.
- 股息收益率：5.46%
- 派珀·桑德勒分析師戴維達姆塞勒維持增持評級，並於4月29日將目標股價從22美元上調至24美元。這位分析師的準確率爲66％。
- 摩根士丹利分析師特倫斯·弗林維持同等權重評級，並於2023年10月11日將目標股價從27美元下調至22美元。該分析師的準確率爲70％。
- 最新消息：Organon宣佈了10億美元優先票據發行的定價。
Bristol-Myers Squibb Company (NYSE:BMY)
百時美施貴寶公司（紐約證券交易所代碼：BMY）
- Dividend Yield: 5.36%
- BMO Capital analyst Evan Siegermanmaintained a Market Perform rating and cut the price target from $55 to $48 on April 26. This analyst has an accuracy rate of 60%.
- Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating and raised the price target from $51 to $52 on April 18. This analyst has an accuracy rate of 77%.
- Recent News: On April 25, Bristol Myers Squibb posted first-quarter revenues of $11.9 billion, beating the consensus of $11.5 billion.
- 股息收益率：5.36%
- BMO Capital分析師埃文·西格曼維持市場表現評級，並於4月26日將目標股價從55美元下調至48美元。這位分析師的準確率爲60％。
- 富國銀行分析師莫希特·班薩爾維持同等權重評級，並於4月18日將目標股價從51美元上調至52美元。這位分析師的準確率爲77％。
- 最新消息：4月25日，百時美施貴寶公佈的第一季度收入爲119億美元，超過了市場普遍預期的115億美元。
Read More: Enbridge, Funko And 3 Stocks To Watch Heading Into Friday
閱讀更多：進入週五，Enbridge、Funko和3只股票值得關注